ww compounded semaglutide reviews WeightWatchers offers version of Ozempic, despite FDA concerns Semaglutide: Injection Home Kit –

Semaglutide has not been shown to cause kidney damage or kidney disease in clinical studies

Energy and Balance A second theme in positive feedback is maintaining a more stable energy level throughout the day

Biosimilar semaglutide development is advancing toward regulatory review by multiple pharmaceutical companies, with FDA biosimilar pathways potentially enabling lower-cost GLP-1 access within the forecast period

You also are not able to claim that the compounded drugs are FDA approved or have an FDA-approved use, or even that the drugs effectiveness was proved in clinical trials, because those all describe the name-brand drugs